findmyKOL
Clinical trialNCT02997696TerminatedPhase 2Interventional

A Study to Evaluate ONO-4474 in Patients With Pain Due to Osteoarthritis of the Knee

SponsorOno Pharmaceutical Co., Ltd.Enrollment70Osteoarthritis, KneePain
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Philip Conaghan, MBBS PhD

    Leeds Institute of Rheumatic and Musculoskeletal Medicine, Chapel Allerton Hospital, Leeds, UK

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

47 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Denmark
  • Investigational Site

    Aalborg, Denmark

  • Investigational Site

    Frederiksberg, Denmark

  • Investigational Site 4504

    Odense, Denmark

Hungary
  • Investigational Site

    Balatonfüred, Hungary

  • Investigational Site

    Budapest, Hungary

  • Investigational Site

    Eger, Hungary

  • Investigational Site

    Kistarcsa, Hungary

  • Investigational Site

    Mezőkövesd, Hungary

  • Investigational Site

    Szolnok, Hungary

Poland
  • Investigational Site 4808

    Bialystok, Poland

  • Investigational Site 4818

    Bialystok, Poland

  • Investigational Site 4819

    Bialystok, Poland

  • Investigational Site

    Elblag, Poland

  • Investigational Site

    Gdynia, Poland

  • Investigational Site

    Katowice, Poland

  • Investigational Site

    Kielce, Poland

  • Investigational Site 4810

    Krakow, Poland

  • Investigational Site 4812

    Krakow, Poland

  • Investigational Site

    Lublin, Poland

  • Investigational Site

    Nadarzyn, Poland

  • Investigational Site

    Poznan, Poland

  • Investigational Site

    Siedlce, Poland

  • Investigational Site

    Staszów, Poland

  • Investigational Site 4811

    Warsaw, Poland

  • Investigational Site 4815

    Warsaw, Poland

  • Investigational Site

    Wroclaw, Poland

  • Investigational Site 4801

    Zamość, Poland

  • Investigational Site 4816

    Zamość, Poland

Spain
  • Investigational Site

    A Coruña, Spain

  • Investigational Site 3406

    Barcelona, Spain

  • Investigational Site 3407

    Barcelona, Spain

  • Investigational Site 3402

    Madrid, Spain

  • Investigational Site 3410

    Madrid, Spain

  • Investigational Site

    Móstoles, Spain

  • Investigational Site

    Sabadell, Spain

  • Investigator Site

    Santiago de Compostela, Spain

  • Investigational Site

    Seville, Spain

  • Investigational Site

    Villajoyosa, Spain

United Kingdom
  • Investigational Site

    Barnsley, United Kingdom

  • Investigational Site

    Blackpool, United Kingdom

7 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Jan 2017
Primary completion
9 Jan 2018
Completion
9 Jan 2018
Last update posted
26 Feb 2018
Registered enrollment
70
Registry id
NCT02997696

Cross-registrations

EU-CTR / CTIS (EudraCT)2016-002675-97

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.